Cargando…

Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease

BACKGROUND: Camel milk (CM) is gaining increasing recognition due to its beneficial effects in the control and prevention of multiple health problems. The current study aimed to investigate the effects of CM on the hepatic biochemical and cellular alterations induced by a high-fat, cholesterol-rich...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korish, Aida A, Arafah, Maha M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852981/ https://www.ncbi.nlm.nih.gov/pubmed/24119413 http://dx.doi.org/10.1186/1472-6882-13-264

Ejemplares similares

Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease
por: AlNafea, Haifa M., et al.
Publicado: (2021)

Camel milk ameliorates inflammatory mechanisms in an alcohol-induced liver injury mouse model
por: Ming, Liang, et al.
Publicado: (2021)

Camel Milk Targeting Insulin Receptor—Toward Understanding the Antidiabetic Effects of Camel Milk
por: Anwar, Irfa, et al.
Publicado: (2022)

Differential Effects of Camel Milk on Insulin Receptor Signaling – Toward Understanding the Insulin-Like Properties of Camel Milk
por: Abdulrahman, Abdulrasheed O., et al.
Publicado: (2016)

Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease
por: Hao, Shiqi, et al.
Publicado: (2022)

Camels, Camel Milk, and Camel Milk Product Situation in Kenya in Relation to the World
por: Oselu, Stephen, et al.
Publicado: (2022)

Ameliorative Effects of Camel Milk and Its Exosomes on Diabetic Nephropathy in Rats
por: Shaban, Amira M., et al.
Publicado: (2022)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
por: Cabrera, Daniel, et al.
Publicado: (2017)

Genistein and exercise modulated lipid peroxidation and improved steatohepatitis in ovariectomized rats
por: Witayavanitkul, Namthip, et al.
Publicado: (2020)

Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion
por: Minami, Yoshito, et al.
Publicado: (2023)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
por: Akter, Sharmin
Publicado: (2022)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Latent potentials of camel’s milk
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Iravani, Farzaneh, et al.
Publicado: (2018)

Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Ahsan, Farah, et al.
Publicado: (2020)

Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver
por: Li, Chao, et al.
Publicado: (2020)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
por: Ghandian, Sina, et al.
Publicado: (2022)

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
por: Bhardwaj, Rishi R., et al.
Publicado: (2010)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis
por: Azeemuddin, Mohammed, et al.
Publicado: (2015)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
por: Zigmond, Ehud, et al.
Publicado: (2014)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2020)

GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress
por: Kim, Hyeon Ju, et al.
Publicado: (2020)

Comparative Attenuating Impact of Camel Milk and Insulin in Streptozotocin-Induced Diabetic Albino Rats
por: Raj, Anshu, et al.
Publicado: (2023)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
por: Yoo, Wonbeak, et al.
Publicado: (2017)

Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway
por: Liu, Yayun, et al.
Publicado: (2019)

Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
por: Daher, Saleh, et al.
Publicado: (2018)

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kim, Jeong Woo, et al.
Publicado: (2020)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
por: Hattori, Sachiko, et al.
Publicado: (2021)

Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis
por: Ma, Mengyao, et al.
Publicado: (2021)

Study of the Biochemical Biodiversity of Camel Milk
por: Bouhaddaoui, Sara, et al.
Publicado: (2019)

Recent Advances in Camel Milk Processing
por: Konuspayeva, Gaukhar, et al.
Publicado: (2021)

The effects of camel chymosin and Withania coagulans extract on camel and bovine milk cheeses
por: Mbye, Mustapha, et al.
Publicado: (2021)

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
por: Takai, Atsuko, et al.
Publicado: (2020)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fg8o76s29b4apis3s54kk26vpl